PAR PHARMACEUTICAL COMPANIES, INC. — Net Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9bd3a916-dc73-46c2-b353-2f75c21d50f2/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2013 | $-105.9M | 2013-01-01 – 2013-12-31 | evidence 0000878088-14-000007 |
| FY 2011 | $-26.1M | 2011-01-01 – 2011-12-31 | evidence 0000878088-12-000027 |
| FY 2010 | $92.7M | 2010-01-01 – 2010-12-31 | evidence 0000878088-12-000027 |
| FY 2009 | $76.9M | 2009-01-01 – 2009-12-31 | evidence 0000878088-12-000027 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
PAR PHARMACEUTICAL COMPANIES, INC. — all facts · Revenue · Operating Income